10 Jim Cramer Stock Picks This Week

Published on December 23, 2022 at 5:08 am by Usman Kabir in Hedge Funds, News

In this article, we discuss the 10 Jim Cramer stock picks this week. If you want to read about some more Jim Cramer stock picks, go directly to 5 Jim Cramer Stock Picks This Week.

Jim Cramer is a former hedge fund manager who hosts the Mad Money show on news platform CNBC. He also runs the CNBC Investing Club and is the co-founder of finance publication The Street. His net worth, as of the end of November 2022, was in excess of $150 million. Cramer is considered a leading expert on the US stock market as he has been involved in stocks for the best part of three decades and finished his hedge fund career with returns of over 24%, becoming a finance guru between 1987 and 2001.

Cramer recently underlined recent comments from Jerome Powell, the chief of the central bank, and noted they had given investors the green-light to invest in stocks. Cramer reminded investors who were worried about the economy tipping into recession that a crisis was still avoidable and there were many segments of the market that could be potential winners in 2023. Some of the stocks that Cramer is bullish on heading into 2023 include The Walt Disney Company (NYSE:DIS), Bank of America Corporation (NYSE:BAC), and The Procter & Gamble Company (NYSE:PG).

Our Methodology

These were picked keeping in mind the latest calls that Cramer made on these equities on his Mad Money show aired by news platform CNBC. Data from around 900 elite hedge funds tracked by Insider Monkey in the third quarter of 2022 was used to identify the number of hedge funds that hold stakes in each firm.

Jim Cramer Stock Picks This Week

10. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 75

Eli Lilly and Company (NYSE:LLY) discovers, develops, and markets human pharmaceuticals worldwide. On December 20, during his Mad Money show on CNBC, Jim Cramer outlined his bullish stance towards the drug firm, singling out the Mounjaro product. The popular investor said that Mounjaro was like a license to print money. Mounjaro is a drug made by the pharma firm for weight loss.

On December 15, UBS analyst Colin Bristow maintained a Buy rating on Eli Lilly and Company (NYSE:LLY) stock and lowered the price target to $420 from $428, highlighting that central tenet of the firm’s thesis is very much intact, with the positive GGG update potentially securing Eli Lilly’s dominant positioning in obesity during the out years.

At the end of the third quarter of 2022, 75 hedge funds in the database of Insider Monkey held stakes worth $5.5 billion in Eli Lilly and Company (NYSE:LLY), compared to 70 the preceding quarter worth $6.7 billion.

Just like The Walt Disney Company (NYSE:DIS), Bank of America Corporation (NYSE:BAC), and The Procter & Gamble Company (NYSE:PG), Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer is bullish on.

In its Q3 2022 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and Eli Lilly and Company (NYSE:LLY) was one of them. Here is what the fund said:

“In the U.S., we initiated a position in pharmaceutical maker Eli Lilly (NYSE:LLY) as it brings out new drug candidates for diabetes and Alzheimer’s disease. New drugs impact diabetes but have also demonstrated significant weight loss for patients who are overweight and have other co-morbidity issues as a result. Lilly is one of the two key players in diabetes care and we believe the potential market opportunity is much higher than the consensus forecasts as we are seeing evidence of accelerating adoption.”

9. Humana Inc. (NYSE:HUM)

Number of Hedge Fund Holders: 76

Humana Inc. (NYSE:HUM) operates as a health and well-being company in the United States. On December 20, during his Mad Money show on CNBC, Jim Cramer outlined his bullish position on the health and well-being firm, noting that the stock was a great turnaround story.

On December 13, Goldman Sachs analyst Nathan Rich upgraded Humana Inc. (NYSE:HUM) to Buy from Neutral with a price target of $652, up from $575, noting that company’s improved competitive positioning in Medicare Advantage has reaccelerated member growth for 2023 and could deliver multiple years of share gains as many peers face Stars headwinds in 2024.

Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Citadel Investment Group is a leading shareholder in Humana Inc. (NYSE:HUM) with 1.2 million shares worth more than $557.6 million.

In its Q3 2022 investor letter, Diamond Hill Capital, an asset management firm, highlighted a few stocks and Humana Inc. (NYSE:HUM) was one of them. Here is what the fund said:

“Humana Inc. (NYSE:HUM) has held up well amid volatile markets given the characteristics of the Medicare Advantage market and expectations that it can return to market growth in the 2023 annual enrollment period. We are confident in Humana’s value creation plan and ability to get back to market enrollment growth in addition to an increasing contribution from its health care services businesses. Shares of Texas Instruments outperformed as the COVID lockdowns eased in China, and customers could accept the product shipments leading to an upside in expectations.”

8. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 85

Johnson & Johnson (NYSE:JNJ) researches and develops, manufactures, and sells various products in the healthcare field. On December 20, Jim Cramer placed the healthcare firm among a basket of stocks that he said would be winners in 2023. Previously, Cramer has said that the firm is a textbook recession-proof stock and exactly the kind of name you want to own when the Federal Reserve decides to slam the brakes on the economy.

On December 12, Citi analyst Joanne Wuensch kept a Buy rating on Johnson & Johnson (NYSE:JNJ) stock and raised the price target to $205 from $198, noting that in 2023 many headwinds remain for the North America medical supplies and technology group, but these should ease in the second half of next year.

Among the hedge funds being tracked by Insider Monkey, Camas, Washington-based firm Fisher Asset Management is a leading shareholder in Johnson & Johnson (NYSE:JNJ) with 5.9 million shares worth more than $967.3 million.

In its Q2 2022 investor letter, Mayar Capital, an asset management firm, highlighted a few stocks and Johnson & Johnson (NYSE:JNJ) was one of them. Here is what the fund said:

“Johnson & Johnson (NYSE:JNJ) is currently our largest position and a long-standing holding. The majority of the group’s sales come from its collection of pharmaceutical franchises, but a large majority (~45%) comes from its collection of medical device businesses and its consumer brands.

Here’s how JNJ make and spends a dollar of revenues: As of 2021, about 55 cents of that dollar comes from its pharmaceutical sales – sales of drugs to pharmacies and distributors – while 30 cents come from the sale of medical devices, such as surgery equipment and orthopaedics. The rest of that dollar in sales comes from sales of JNJ’s consumer brands such as Listerine mouthwash, Nicorette nicotine tablets and Neutrogena cosmetics (…read more)

7. Caterpillar Inc. (NYSE:CAT)

Number of Hedge Fund Holders: 43

Caterpillar Inc. (NYSE:CAT) manufactures and sells construction and mining equipment, diesel and natural gas engines, and industrial gas turbines. On December 20, during his Mad Money show on CNBC, Jim Cramer gave a bullish thesis on the firm, noting that the stock had much more exposure to infrastructure, and also had a boost coming from the oil and gas industry. Cramer added that the shares were definitely worth owning at 17 times earnings.

On December 19, Stifel analyst Stanley Elliott maintained a Buy rating on Caterpillar Inc. (NYSE:CAT) stock and raised the price target to $271 from $260, noting that it is expected that the price/cost environment will generally improve, including slowness in housing.

At the end of the third quarter of 2022, 43 hedge funds in the database of Insider Monkey held stakes worth $2.8 billion in Caterpillar Inc. (NYSE:CAT), compared to 45 in the previous quarter worth $3.2 billion.

In its Q1 2022 investor letter, Diamond Hill Capital, an asset management firm, highlighted a few stocks and Caterpillar Inc. (NYSE:CAT) was one of them. Here is what the fund said:

“We also initiated a position in Caterpillar (NYSE:CAT), one of the world’s leading manufacturers of construction and mining equipment. It’s a company we know well, as we have owned it in our large-cap portfolio for quite some time. Recent share price weakness provided an opportunity for us to add it to our large-cap concentrated portfolio at an attractive discount to our estimate of intrinsic value. We believe Caterpillar stands to benefit from increased capital investment supported by a healthier/recovering end market environment, particularly in construction and mining.”

6. Deere & Company (NYSE:DE)

Number of Hedge Fund Holders: 57

Deere & Company (NYSE:DE) manufactures and distributes various equipment worldwide. On December 20, Jim Cramer gave his take on the firm during his Mad Money show on CNBC, placing it among a basket of stocks that he thought would be winners in 2023 and also end 2022 as outperformers of the broader market.

On December 19, investment advisory Stifel maintained a Buy rating on Deere & Company (NYSE:DE) stock and raised the price target to $477 from $475. Analyst Stanley Elliott issued the ratings update.

Among the hedge funds being tracked by Insider Monkey, Chicago-based investment firm Bill & Melinda Gates Foundation Trust is a leading shareholder in Deere & Company (NYSE:DE) with 3.9 million shares worth more than $1.3 billion.

Along with The Walt Disney Company (NYSE:DIS), Bank of America Corporation (NYSE:BAC), and The Procter & Gamble Company (NYSE:PG), Deere & Company (NYSE:DE) is one of the stocks that Jim Cramer is bullish on.

In its Q3 2022 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks and Deere & Company (NYSE:DE) was one of them. Here is what the fund said:

“For example, we believe that farm equipment manufacturer Deere & Company (NYSE:DE) continues to benefit from both a strong farm economy and product innovations that directly benefit farmers’ productivity while also reducing their environmental footprint. The company has also demonstrated excellent execution, highlighted by capturing market share and maintaining margins despite dealing with a labor strike and elevated supply chain costs.”

Click to continue reading and see 5 Jim Cramer Stock Picks This Week.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up